Biofluid sample prep kits, 9/13:103

Qiagen announced a partnership with Exosome Diagnostics to develop and commercialize high-performance biofluid sample preparation kits for the processing of nucleic acids from exosomes.

Combining Exosome Diagnostics’ platform technology approach with select Qiagen consumables and automation platforms has the potential to allow researchers, drug developers, and medical professionals to take repeated, real-time genetic “snapshots” of disease from patients’ blood, urine, or cerebrospinal fluid without the need for tissue biopsy.

Qiagen’s exosome technology-driven kits will offer the ability to work with scalable patient sample volumes from as little as 200 L; RNA capture from frozen, bio-banked fluids; and plasma, urine, and CSF with no special stabilization or handling required. It will offer a streamlined clinical laboratory workflow for analysis on PCR, pyrosequencing, and next-generation sequencing instruments. Previously, such analysis would have depended on the use of tissue or cells, or both, potentially requiring invasive procedures.

Qiagen, 800-426-8157

Exosome Diagnostics, 646-843-4926